NAPLEX Practice Exam 2025 – Comprehensive Test Preparation

Fosaprepitant is the correct answer because it is available in both oral and intravenous forms for managing chemotherapy-induced nausea and vomiting (CINV). This dual formulation allows for flexibility in administration based on the patient's needs and clinical scenario.

Aprepitant (Choice A) is available in oral form only, while ondansetron (Choice C) and palonosetron (Choice D) are both available in oral and injectable forms. However, the unique aspect of fosaprepitant lies in its dual formulation, making it the best choice among the options provided for this particular characteristic.